PFG
AMPE

Piershale Financial Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Piershale Financial Group’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2
Closed – – 151
2016
Q3 		$0 Hold
2
– – ﹤0.01% 177
2016
Q2 		$1K Hold
2
– – ﹤0.01% 137
2016
Q1 		$1K Hold
2
– – ﹤0.01% 133
2015
Q4 		$2K Hold
2
– – ﹤0.01% 180
2015
Q3 		$1K Hold
2
– – ﹤0.01% 130
2015
Q2 		$1K Buy
+2
New +$2.13K ﹤0.01% 105

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Piershale Financial Group's AMPE Position: Q4 2016 in Review

Piershale Financial Group sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2016, closing a stake of 2 shares.

Piershale Financial Group first reported a position in AMPE in Q2 2015 and held it in 6 quarters. The position peaked at $2K in Q4 2015. 71 funds tracked by Wall St. Rank hold AMPE as of Q4 2016.

  • Piershale Financial Group reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2016 after selling out during the quarter.
  • Piershale Financial Group sold 2 Ampio Pharmaceuticals Inc. shares in Q4 2016.
  • Piershale Financial Group first reported a position in Ampio Pharmaceuticals Inc. in Q2 2015 and held it in 6 quarters.
  • Piershale Financial Group's Ampio Pharmaceuticals Inc. position peaked at $2K in Q4 2015.
  • 71 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2016.

Based on Piershale Financial Group's 13F filing for Q4 2016, filed 18 Jan 2017.